NCT00903578Unknown不适用
Impact of FGF-23 and Serum Phosphate on Allograft Function and Mortality in Kidney Allograft Recipients
适应症
试验速览
- 阶段
- 不适用
- 入组人数
- 200
- 试验地点
- 1
- 主要终点
- Progression of allograft dysfunction and all-cause Mortality
研究概览
简要总结
The present study will examine whether serum FGF-23 and serum phosphate at baseline of kidney transplant recipients can predict progression of allograft dysfunction at 3 years and all-cause mortality at 5 years.
研究设计
- 研究类型
- Observational
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •at least one year post-transplantation
- •no more than 10% increase in serum creatinine for the past 3 months
排除标准
- •refuse to participate in the study
- •any acute illnesses
结局指标
主要结局
Progression of allograft dysfunction and all-cause Mortality
时间窗: 3 and 5 years
次要结局
- Relationship of FGF-23 and 25-OH-D, 1-25-OH-D, PTH, calcium, phosphate, urine phosphate and eGFR(1 year)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
The effect of renal phosphate clearance on serum fibroblats growth factor 23 (FGF23) in patients on peritonela dialysisJPRN-UMIN000009315Department of Integrated Therapy for Chronic Kidney Disease, Graduate School of Medical Sciences, Kyushu University60
已完成
不适用
FGF-23 and PTH in Hemodialysis PatientsChronic Kidney Disease Requiring Chronic DialysisNCT04350944Medical University of Vienna30
已完成
不适用
Effect of phosphate binder on serum level of FGF23: A comparison between ferric citrate hydrate and lanthanum carbonate.chronic kidney diseaseJPRN-UMIN000019669Hyogo College of Medicine20
已完成
不适用
FGF-23 (Fibroblast Growth Factor 23) Regulation in Chronic Kidney DiseaseSecondary HyperparathyroidismNCT00999037University of California, Los Angeles18
已完成
4 期
Effect of Phosphate Binders on FGF-23 With Concurrent CalcitriolChronic Kidney Disease Stage 3NCT01748396Seoul National University Hospital30